Arbutus Biopharma Corp
ABUS
Rank in Stocks
#10154
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company,... Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients’ HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Share Price
$3.72
Last synced: 2026-11-09
Market Cap
$736.95M
Change (1 day)
1.78%
Change (1 year)
-23.14%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Arbutus Biopharma Corp (ABUS)
Category
Healthcare
Dividend yield history for Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (stock symbol: ABUS) dividend yield (TTM) as of 2025: 0.00%
Average dividend yield, last 5 years : 0.59%
Average dividend yield, last 5 years : 0.59%
Dividend yield history for Arbutus Biopharma Corp (ABUS) from 2000 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | 2.94% | -34.67% |
| 2020 | 4.50% | -35.90% |
| 2019 | 7.02% | 47.48% |
| 2018 | 4.76% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.02% |
AU
|
|
| 0.52% |
BE
|
|
| 0.00% |
NL
|
Questions about Arbutus Biopharma Corp's dividend yield
What was Arbutus Biopharma Corp's dividend yield in 2025?
In 2025, Arbutus Biopharma Corp's dividend yield was 0.00%, compared with 0.00% in 2024.
How has Arbutus Biopharma Corp's dividend yield changed since 2020?
From 2020 to 2025, Arbutus Biopharma Corp's dividend yield was highest in 2020 (4.50%) and lowest in 2025 (0.00%).
How does Arbutus Biopharma Corp's dividend yield compare with similar companies?
Arbutus Biopharma Corp's dividend yield (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is CSL Limited, with 2.02%.